Leah Flatman: Patterns of Use and Discontinuation for TNF Inhibitors in Pregnant Women
Leah Flatman, Postdoctoral Fellow at Centre de recherche Azrieli du CHU Sainte-Justine, shared a post by The Journal of Rheumatology on LinkedIn:
“I am very grateful to The Journal of Rheumatology for publishing our recent study on TNF inhibitor use during pregnancy: Patterns of Use and Discontinuation for Tumor Necrosis Factor Inhibitors in Pregnant Women: Insights From a Real-World Sample.
I am also grateful to Laura Andreoli, Mette Julsgaard, and Karen Schreiber for their thoughtful commentary. Together, our articles highlight a key reality in pregnancy research: it has taken over a decade for TNF inhibitors to be used confidently in pregnancy, underscoring the need to generate safety data earlier in drug development.
We fully agree that better-informed decisions start with stronger evidence early on. Integrating pregnancy data into clinical development could make a real difference for women with chronic diseases who are planning a family.
It’s encouraging to see regulatory frameworks evolving, and collaborations between researchers, clinicians, and regulators will be essential to ensuring safe and effective treatments for mothers and babie.”
Quoting The Journal of Rheumatology’s post:
“Research Article
Patterns of Use and Discontinuation for Tumor Necrosis Factor Inhibitors in Pregnant Women: Insights From a Real-World Sample.”
Title: Patterns of Use and Discontinuation for Tumor Necrosis Factor Inhibitors in Pregnant Women: Insights From a Real-World Sample
Authors: Leah K. Flatman, Sasha Bernatsky, Anick Bérard, Évelyne Vinet
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Mar 21, 2026, 15:00Samantha Butts Shares Personal and Professional Insights in ASRM Close Up
-
Mar 21, 2026, 14:47Scammers Are Targeting ESHRE2026 Attendees – ESHRE
-
Mar 21, 2026, 14:26No Obvious Harm From Prolonged Oocyte Cryostorage – RBMO
-
Mar 21, 2026, 14:13Empowering Change: Health Systems at the Forefront of Ending FGM/C! – FIGO
-
Mar 21, 2026, 09:56Expanded Carrier Screening: Clinical, Ethical, and Psychosocial Perspectives from Ghent – ESHRE
-
Mar 21, 2026, 09:53Impact of Male Obesity on Embryo Development and Miscarriage Risk – Fertility and Sterility
-
Mar 20, 2026, 17:06Christopher Robinson: AJOG Expert Review on Placenta Accreta After Cesarean
-
Mar 20, 2026, 16:53HCG Failure and Trigger Strategies in IVF – Fertility Plus
-
Mar 20, 2026, 16:38Secure Your Early Bird Ticket for RCOG Annual Professional Development Conference – RCOG